How do SCFAs modulate cardiometabolic risk in normal-weight adults?

How SCFAs modulate cardiometabolic disease risk by interacting with an individual’s adiposity parameters and diet.

Kidney Week Roundup: Cell Therapy Cuts Immunosuppressive Drug Use Post-Transplant

PHILADELPHIA — Some of the latest research in the field of nephrology presented at the American Society of Nephrology’s Kidney Week included sparsentan in focal

November 8, 2023

FDA approves Lilly’s eczema drug Ebglyss for moderate-to-severe disease

Eli Lilly’s drug lebrikizumab has been approved for the treatment of eczema, or atopic dermatitis, a win for the company after the FDA rejected the

September 17, 2024

Bioengineering firm Ossium Health raises $52m in Series C

Bone marrow 3d illustration. Credit: sciencepics / Shutterstock.com. Bioengineering company Ossium Health has secured $52m in Series C funding for expanding its bone marrow stem

July 26, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.